Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENNOBLE-ATE: Edoxaban in pediatric cardiac disease
NCT03395639Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of edoxaban in thromboembolism, sponsored by Daiichi Sankyo Co., Ltd.. Started May 2018; status: completed.
02
Drugs
edoxaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT03395639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395639.